Curated dataset · n=61 verified deals · Not live market data · Scores are descriptive, not forecasts.
You are here

Deals — Network graph, deal flow, valuation matrix, and acquirer landscape.

Apostrophe
→
Hims & Hers Health

Acquisition · Cash · announced Jun 24, 2021

View in network
  1. Announced

    Jun 24, 2021

  2. Closed

    Jul 7, 2021

Economics

Cash

Up to ~$190M total: ~$150M upfront (~$50M cash plus 8.07M HIMS shares) plus up to $50M earnout on revenue targets (Hims & Hers investor relations, June–July 2021)

Target

Apostrophe

General Wellness · Consumer wellness

HQ San Francisco, CA · Founded 2014

Teledermatology platform with personalized treatment plans and compounding pharmacy; majority female user base

  • Hims & Hers investor relations press release (June 24, 2021)
  • Business Wire - acquisition completion (July 7, 2021)
  • MobiHealthNews coverage (June 2021)

Acquirer

Hims & Hers Health

Healthcare

HQ San Francisco, CA

Multi-specialty telehealth platform for men's and women's health

Why this buyer

Curated copy from the verified dataset — not an 8-K LLM summary

Added teledermatology and compounding pharmacy capability to expand personalized women's skin health offerings

Evidence ladder

Press only — no primary filingValue disclosed
  1. Tertiary (trade / analyst)

    Hims & Hers investor relations (June 24, 2021)

  2. Secondary (press / IR)

    Business Wire (July 7, 2021)

Limitations

  • Citations are press/IR only — two wires of the same announcement are not dual-source. Add a primary filing.
  • Up to ~$190M total: ~$150M upfront (~$50M cash plus 8.07M HIMS shares) plus up to $50M earnout on revenue targets (Hims & Hers investor relations, June–July 2021)

Valuation peers · General Wellness

Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer, until you sort.

Why included
NurxRoDec 15, 2021same evidence class

Same-sector adjacency — not valuation peers

These deals share the sector tag and window but sit outside the 0.25×–4× value band. The dataset keeps them for clinical adjacency, not as price comps.

Vs this deal
Livongo HealthTeladocAug 5, 2020

Other verified deals by Hims & Hers Health

Acquirer program history not already listed as a valuation peer or adjacency row.

No further verified deals

Other verified transactions by Hims & Hers Health are already listed above, or none are in the dataset.

Patient empowerment context

Patient empowerment baseline (HLTH 2022)

No curated mapping — Apostrophe (General Wellness). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.

Research workspace (includes heuristic crosswalk) →

Related verified workspaces

Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.

Curated verified dataset v11 · updated 2026-10-19 · 2 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.